A detailed history of Phoenix Holdings Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Phoenix Holdings Ltd. holds 31,332 shares of LLY stock, worth $19.9 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
31,332
Previous 24,889 25.89%
Holding current value
$19.9 Million
Previous $20.6 Million 18.82%
% of portfolio
0.33%
Previous 0.32%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 30, 2025

BUY
$713.71 - $898.95 $4.6 Million - $5.79 Million
6,443 Added 25.89%
31,332 $24.4 Million
Q1 2025

May 07, 2025

BUY
$725.72 - $929.72 $4.25 Million - $5.44 Million
5,852 Added 30.74%
24,889 $20.6 Million
Q4 2024

Feb 13, 2025

BUY
$727.2 - $932.06 $1.52 Million - $1.95 Million
2,096 Added 12.37%
19,037 $14.7 Million
Q3 2024

Nov 05, 2024

SELL
$772.14 - $960.02 $493,397 - $613,452
-639 Reduced 3.63%
16,941 $15 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $5.26 Million - $6.6 Million
7,258 Added 70.32%
17,580 $15.9 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $878,824 - $1.18 Million
1,484 Added 16.79%
10,322 $8.03 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $1.31 Million - $1.54 Million
2,488 Added 39.18%
8,838 $5.15 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $470,780 - $649,041
1,083 Added 20.56%
6,350 $3.41 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $418,082 - $559,024
1,192 Added 29.25%
5,267 $2.47 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $642,072 - $754,082
2,067 Added 102.94%
4,075 $1.4 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $29,904 - $34,844
93 Added 4.86%
2,008 $734,000
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $285,213 - $325,030
962 Added 100.94%
1,915 $632,000
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $265,629 - $311,888
953 New
953 $309,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $604B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Phoenix Holdings Ltd. Portfolio

Follow Phoenix Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Phoenix Holdings Ltd. with notifications on news.